Format

Send to

Choose Destination
Toxicol Appl Pharmacol. 2012 Dec 15;265(3):292-9. doi: 10.1016/j.taap.2012.08.028. Epub 2012 Sep 6.

Sulforaphane prevents pulmonary damage in response to inhaled arsenic by activating the Nrf2-defense response.

Author information

1
Department of Environmental and Occupational Health, School of Public Health, China Medical University, Shenyang, Liaoning 110001, China.

Abstract

Exposure to arsenic is associated with an increased risk of lung disease. Novel strategies are needed to reduce the adverse health effects associated with arsenic exposure in the lung. Nrf2, a transcription factor that mediates an adaptive cellular defense response, is effective in detoxifying environmental insults and prevents a broad spectrum of diseases induced by environmental exposure to harmful substances. In this report, we tested whether Nrf2 activation protects mice from arsenic-induced toxicity. We used an in vivo arsenic inhalation model that is highly relevant to low environmental human exposure to arsenic-containing dusts. Two-week exposure to arsenic-containing dust resulted in pathological alterations, oxidative DNA damage, and mild apoptotic cell death in the lung; all of which were blocked by sulforaphane (SF) in an Nrf2-dependent manner. Mechanistically, SF-mediated activation of Nrf2 alleviated inflammatory responses by modulating cytokine production. This study provides strong evidence that dietary intervention targeting Nrf2 activation is a feasible approach to reduce adverse health effects associated with arsenic exposure.

PMID:
22975029
PMCID:
PMC3725323
DOI:
10.1016/j.taap.2012.08.028
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center